Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • News
    • Implants / Devices
    • Biocon Chief Kiran...

    Biocon Chief Kiran Shaw, FM Nirmala Sitharaman in tiff over E-Cigarette ban

    Farhat NasimWritten by Farhat Nasim Published On 2019-09-20T17:01:23+05:30  |  Updated On 16 Aug 2021 2:13 PM IST

    New Delhi: Biocon Chief Kiran Mazumdar Shaw recently got into a spat with the Finance Minister Nirmala Sitharaman on Thursday. The minister defended her handling of the economy saying she has been working on measures to revive the growth from a six-year low.


    Sitharaman, who is not known to reply to comments made on her twitter handle, instantly choose to respond to drug-maker Biocon Chairman Kiran Mazumdar-Shaw's criticism of lack of fiscal measures to support growth.





    Shaw had wondered why Finance Minister, and not the health minister, addressed the press conference on Wednesday to announce a ban on e-cigarettes.





    Sitharaman clarified that she had addressed the press conference on Wednesday in her capacity as head of the group of ministers (GoM) that had gone into the issue of ban on e-cigarettes.





    She had also mentioned at the press conference on Wednesday that Health Minister Harsh Vardhan was travelling out of the country.





    And followed it up with a third tweet on working on matters of the economy.


    With her maiden budget on July 5 seemingly failing to address issues facing the economy and doing little to bolster growth that has slowed to a six-year low and check unemployment that's risen to a 45-year high, Sitharaman has over the past one month announced in measures in three tranches for different sectors of the economy including automobiles, banks and real estate.


    Also Read: We need measures to save jobs in Automotive Sector: Biocon MD Kiran Mazumdar Shaw


    While she had pre-budget meetings with top representatives of various sectors to understand their requirements and issues facing them, the finance minister met different sectoral officials again within weeks of the Budget presentation and has repeatedly stated that these meetings formed the basis for the measures she has announced in three tranches.


    India's GDP growth slowed for the fifth consecutive quarter in April-June 2019 to 5 per cent, the lowest in six years. This was on the back of faltering domestic demand, with both private consumption and investment proving lackluster.


    In response, her initial policy measures included support for the automobile sector, reduction in capital gains tax, and additional liquidity support for shadow banks. Accompanying structural reforms included a further easing of the foreign direct investment (FDI) regime and consolidation of the public banking sector.


    In the third part, she on last Saturday (September 14) announced a stressed asset fund to fund unfinished real estate projects and measures to boost exports.


    There are expectations that she may announce the fourth tranche of measures soon.


    With some on Twitterati seeing the exchange as a spat, Shaw tweeted again to clarify it wasn't.




    Bioconcigarette bane-cigaretteecigaretteeconomyface offFinance minister of indiaGutkaHealth MinisterHealth MinistryIndiaIndian economyindian finance ministerkiranKiran Mazumdar ShawKiran Vs SitharamanNirmala Sitharamanpharmapharma newspharma news indiaTaxTwittertwitter post
    Source : PTI

    Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2020 Minerva Medical Treatment Pvt Ltd

    Farhat Nasim
    Farhat Nasim

      Farhat Nasim joined Medical Dialogue an Editor for the Business Section in 2017. She Covers all the updates in the Pharmaceutical field, Policy, Insurance, Business Healthcare, Medical News, Health News, Pharma News, Healthcare and Investment. She is a graduate of St.Xavier’s College Ranchi. She can be contacted at editorial@medicaldialogues.in Contact no. 011-43720751 To know about our editorial team click here

      Show Full Article
      Next Story
      Similar Posts
      NO DATA FOUND

      Popular Stories

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 13 Oct 2022 5:14 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok